

Ramgopal Rao
Board Member
My Story
Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is inventor, founder, and chief executive officer of LensGen, Inc., a clinical stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world. LensGen closed a $28.0 million Series A Financing in May 2018.
​
Currently he is also Chairman of the Board of 2C Tech Corporation, Inc., an emerging medical device company that is developing a novel nanotechnology application for preservation of vision for patients with degenerative retinal diseases. 2C Tech Completed Series B Financing in 2016 and 2019.
​
Ram co-developed an innovative corneal implant device for presbyopia and licensed the technology to (venture funded) Acufocus, Inc. The company is now commercializing the product on a global scale. Prior to that, Ram founded Tomey Technology Inc., that pioneered the corneal topography imaging technology that is now a standard of care in eye care for LASIK and cataract surgery. This joint venture company was acquired by Tomey Corporation of Japan.
​
He was Chief Operating Officer and Director of Vitreoretinal Technologies, Inc., a venture funded ophthalmic pharmaceutical company that developed a drug for diabetic retinopathy.
Ram was President of Ophthalmic Group at Premier Laser Systems, Inc.; a publicly held company that developed the first laser assisted cataract surgery technology. He also held various executive positions at Biorad Laboratories, Inc.
​
Contact
"Your feedback and recommendations are always welcome—let's create something great together!"
(714) 728-7100